These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ependymoma AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
77 results:

  • 1. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.
    Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A
    Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The pontine diffuse midline glioma, egfr-subtype with ependymal features: Yet another face of diffuse midline glioma, H3K27-altered.
    Tauziède-Espariat A; Métais A; Mariet C; Castel D; Grill J; Saffroy R; Hasty L; Dangouloff-Ros V; Boddaert N; Benichi S; Chrétien F; Varlet P
    Brain Pathol; 2024 Jan; 34(1):e13181. PubMed ID: 37331375
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mutation Profiling of Intracranial Myxopapillary ependymoma by Next Generation DNA Sequencing.
    Taher MM; Alhussini AA; Saeed M; Athar M; Bantan NAA; Jastania RA; Balkhoyour KB; Nageeti TH
    Gulf J Oncolog; 2021 Sep; 1(37):7-16. PubMed ID: 35152189
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
    Rana R; Sharma S; Ganguly NK
    Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comprehensive analysis of the erbb receptor family in pediatric nervous system tumors and rhabdomyosarcoma.
    Varlet P; Bouffet E; Casanova M; Giangaspero F; Antonelli M; Hargrave D; Ladenstein R; Pearson A; Hawkins C; König FB; Rüschoff J; Schmauch C; Bühnemann C; Garin-Chesa P; Schweifer N; Uttenreuther-Fischer M; Gibson N; Ittrich C; Krämer N; Solca F; Stolze B; Geoerger B
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29316. PubMed ID: 34546642
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A phase II study of dose-dense temozolomide and lapatinib for recurrent low-grade and anaplastic supratentorial, infratentorial, and spinal cord ependymoma.
    Gilbert MR; Yuan Y; Wu J; Mendoza T; Vera E; Omuro A; Lieberman F; Robins HI; Gerstner ER; Wu J; Wen PY; Mikkelsen T; Aldape K; Armstrong TS
    Neuro Oncol; 2021 Mar; 23(3):468-477. PubMed ID: 33085768
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas.
    Schieffer KM; Agarwal V; LaHaye S; Miller KE; Koboldt DC; Lichtenberg T; Leraas K; Brennan P; Kelly BJ; Crist E; Rusin J; Finlay JL; Osorio DS; Sribnick EA; Leonard JR; Feldman A; Orr BA; Serrano J; Vasudevaraja V; Snuderl M; White P; Magrini V; Wilson RK; Mardis ER; Boué DR; Cottrell CE
    Am J Surg Pathol; 2021 Mar; 45(3):329-340. PubMed ID: 33074854
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
    Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
    F1000Res; 2019; 8():613. PubMed ID: 32612806
    [No Abstract]    [Full Text] [Related]  

  • 9. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre.
    Jaunmuktane Z; Capper D; Jones DTW; Schrimpf D; Sill M; Dutt M; Suraweera N; Pfister SM; von Deimling A; Brandner S
    Acta Neuropathol Commun; 2019 Feb; 7(1):24. PubMed ID: 30786920
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics.
    Velázquez Vega JE; Brat DJ
    Adv Anat Pathol; 2018 May; 25(3):143-171. PubMed ID: 29521646
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Neurological update: gliomas and other primary brain tumours in adults.
    Brandner S; Jaunmuktane Z
    J Neurol; 2018 Mar; 265(3):717-727. PubMed ID: 29098416
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel
    Servidei T; Meco D; Muto V; Bruselles A; Ciolfi A; Trivieri N; Lucchini M; Morosetti R; Mirabella M; Martini M; Caldarelli M; Lasorella A; Tartaglia M; Riccardi R
    Cancer Res; 2017 Nov; 77(21):5860-5872. PubMed ID: 29092923
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Glioma Subclassifications and Their Clinical Significance.
    Chen R; Smith-Cohn M; Cohen AL; Colman H
    Neurotherapeutics; 2017 Apr; 14(2):284-297. PubMed ID: 28281173
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
    Jakacki RI; Foley MA; Horan J; Wang J; Kieran MW; Bowers DC; Bouffet E; Zacharoulis S; Gill SC
    J Neurooncol; 2016 Aug; 129(1):131-8. PubMed ID: 27287856
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.
    Liang L; Olar A; Niu N; Jiang Y; Cheng W; Bian XW; Yang W; Zhang J; Yemelyanova A; Malpica A; Zhang Z; Fuller GN; Liu J
    Am J Surg Pathol; 2016 Jun; 40(6):847-56. PubMed ID: 26990854
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
    Friedrich C; von Bueren AO; Kolevatova L; Bernreuther C; Grob T; Sepulveda-Falla D; van den Boom L; Westphal M; Simon R; Glatzel M
    Childs Nerv Syst; 2016 Feb; 32(2):281-90. PubMed ID: 26686534
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Nucleolin overexpression is associated with an unfavorable outcome for ependymoma: a multifactorial analysis of 176 patients.
    Chen C; Chen L; Yao Y; Qin Z; Chen H
    J Neurooncol; 2016 Mar; 127(1):43-52. PubMed ID: 26615563
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study.
    Chen X; Li C; Che X; Chen H; Liu Z
    Acta Neurochir (Wien); 2016 Jan; 158(1):101-7. PubMed ID: 26577638
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The genetic basis of intradural spinal tumors and its impact on clinical treatment.
    Karsy M; Guan J; Sivakumar W; Neil JA; Schmidt MH; Mahan MA
    Neurosurg Focus; 2015 Aug; 39(2):E3. PubMed ID: 26235020
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Intramedullary spinal cord tumors: a review of current and future treatment strategies.
    Tobin MK; Geraghty JR; Engelhard HH; Linninger AA; Mehta AI
    Neurosurg Focus; 2015 Aug; 39(2):E14. PubMed ID: 26235012
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.